Not all patients diagnosed with OSA are obese, in fact, OSA is present in approximately 40% of people affected by obesity. AHA Journals GLP-1 medications are not a cure for sleep apnea, but they can help improve or even resolve it in some cases by addressing one of the major underlying causes of sleep apnea, if that cause is specifically obesity
Low levels may contribute to fatigue, brain fog, and neurological symptoms
Like other GLP-1 drugs, Foundayo can cause side effects such as nausea, constipation, diarrhea, vomiting, abdominal pain, and headache, according to the FDA
Further, clinicians have only recently begun to consider the unique advantages of nasal administration, spurring the development of pharmaceuticals that are highly bioavailable via the nasal mucosa
plus ongoing medical supervision and wellness support, all included in your plan